Primary and metastatic malignant tumors of the scalp: An update

American Journal of Clinical Dermatology

Volumn 11, Issue 4, 2010, Pages 233-246

  Richmond, Heather M ^a   Duvic, Madeleine ^a   MacFarlane, Deborah F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CELECOXIB; CURCUMIN; DENILEUKIN DIFTITOX; DOXORUBICIN; EFLORNITHINE; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GEMCITABINE; GENISTEIN; GRAPE SEED EXTRACT; IMIQUIMOD; LYCOPENE; RETINOID; SILYMARIN; TAZAROTENE;

ACTINIC KERATOSIS; APOCRINE GLAND CARCINOMA; ATYPICAL FIBROXANTHOMA; AUTOSOMAL DOMINANT DISORDER; B CELL LYMPHOMA; BASAL CELL CARCINOMA; BOWEN DISEASE; BROOKE SYNDROME; CANCER EPIDEMIOLOGY; CANCER SURGERY; CHEMOPROPHYLAXIS; CHEMOSURGERY; CLEAR CELL ACANTHOMA; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CUTANEOUS ANGIOSARCOMA; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FIBROXANTHOMA; HUMAN; IMMUNOCOMPROMISED PATIENT; KERATOACANTHOMA; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOSCINTIGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MERKEL CELL TUMOR; METASTASIS; MICROCYSTIC ADNEXAL CARCINOMA; MYCOSIS FUNGOIDES; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SCALP TUMOR; SEBACEOUS CARCINOMA; SEBACEOUS NEVUS; SKIN LYMPHOMA; SQUAMOUS CELL CARCINOMA; SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM; T CELL LYMPHOMA; TRICHOBLASTOMA; TUMOR LOCALIZATION;

CHEMOPREVENTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, CUTANEOUS; NEOPLASM METASTASIS; PHOTOCHEMOTHERAPY; SCALP; SKIN NEOPLASMS;

EID: 77952979511     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11533260-000000000-00000     Document Type: Review

References (68)

1. Carlson J, Scott D, Wharton J, et al. Incidental histopathologic patterns: possible evidence of 'field cancerization' surrounding skin tumors. Am J Dermatopathol 2001 Oct; 23 (5): 494-496
2. Tran H, Chen K, Shumack S. Summary of actinic keratosis studies with imiquimod 5% cream. Br J Dermatol 2003; 149 Suppl. 66: 37-39
3. Morton C, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002 Apr; 146 (4): 552-567
4. Leibovitch I, Huilgol S, Richards S, et al. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome. Dermatol Surg 2006; 32: 1369-1374
5. Wright T, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 2006; 54: 933-946
6. Chiu C, Lin CY, Kuo CY, et al. Malignant cutaneous tumors of the scalp: a study of demographic characteristics and histologic distributions of 398 Taiwanese patients. J Am Acad Dermatol 2007; 56: 448-452
7. Hayman L, Shukla V, Ly C, et al. Clinical and imaging anatomy of the scalp. J Comput Assist Tomogr 2003 Jun; 27 (3): 454-459
8. Minor L, Panje WR. Malignant neoplasms of the scalp: etiology, resection, and reconstruction. Otolaryngol Clin North Am 1993 Apr; 26 (2): 279-293
9. Leedy J, Janis JE, Rohrich RJ. Reconstruction of acquired scalp defects: an algorithmic approach. Plast Reconstr Surg 2005; 116 (4): 54e-72e
10. Shah K, Onufer J, MacFarlane DF. Imaging of head and neck skin cancer. In: MacFarlane DF, editor. Skin cancer management: a practical approach. New York: Springer, 2010: 239-258
11. Katz T, Silapunt S, Goldberg LH, et al. Analysis of 197 female scalp tumors treated with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52: 291-294
12. Abe S, Yamamoto Y, Uno S, et al. Malignant melanoma arising in a sebaceous nevus of the scalp. Br J Plast Surg 2003; 56: 171-173
13. Kohler H, Neves RI, Brechtbuhl ER, et al. Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg 2008 Oct; 139 (4): 519-524
14. Roesch-Ely M, Nees M, Karsai S, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007 Jan 4; 26 (1): 54-64
15. Stern R, Bolshakov S, Nataraj AJ, et al. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 2002; 119: 522-526
16. Kanjilal S, Strom SS, Clayman GL, et al. p53Mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995 Aug; 55 (16): 3604-3609
17. GoldM,NestorMS. Current treatments of actinic keratosis. JDrugsDermatol 2006; 5 (2 Suppl.): 17-25
18. Duvic M, Ni X, Talpur R, et al. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 2003; 121: 902-909
19. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ. Arch Dermatol 2006; 142: 729-735
20. Naylor M. Imiquimod and superficial skin cancers. J Drugs Dermatol 2005; 4 (5): 598-606
21. Peris K, Fargnoli MC, Chimenti S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Engl JMed 1999 Dec; 341 (23): 1767-1768
22. Po-Lin S, Lee K, Herbert J, et al. Topical tazarotene chemoprevention reduces basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation. Cancer Res 2004; 64: 4385-4389
23. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990 Jun; 6 (1-2): 143-148
24. Nestor M, Gold MH, Kauvar AN, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006 Feb; 5 (2): 140-154
25. Kache A, Luderschmidt S, Ring J, et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006 Apr; 5 (4): 353-356
26. Brown V,Atkins CL, Ghali L, et al. Safety and efficacy of 5%imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients. Arch Dermatol 2005; 141: 985-993
27. Perrett C, McGregor JM, Warwick J, et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br JDermatol 2007; 156: 320-328
28. Robak E, Robak T. Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma 2007 May; 48 (5): 855-865
29. Yarosh D, Klein J, O'Connor A, et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study. Xeroderma Pigmentosum Study Group. Lancet 2001 Mar; 357 (9260): 926-929
30. Mohs F, Zitelli JA. Microscopically controlled surgery in the treatment of carcinoma of the scalp. Arch Dermatol 1981; 117: 764-769
31. Belhocine T, Scott AM, Even-Sapir E, et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006; 47: 957-967
32. Morton D, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006 Sept; 355 (13): 1307-1317
33. Chao C,Wong SL, EdwardsMJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003 Jan-Feb; 10 (1): 21-26
34. Kilpatrick L, Shen P, Stewart JH, et al. Use of sentinel lymph node biopsy for melanoma of the head and neck. Am Surg 2007 Aug; 73 (8): 754-8; discussion 8-9
35. Willis A, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck 2007; 29: 979-985
36. Seavolt M, McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with Mohs micrographic surgery. Dermatol Surg 2006; 32: 435-441
37. Giuffrida T, Kligora CJ, Goldstein GD. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004; 30: 1561-1564
38. Jensen K, Peterson SR. Multiple recurrent atypical fibroxanthomas/ superficial malignant fibrous histiocytomas of the forehead excised with Mohs micrographic surgery (MMS). Dermatol Surg 2006; 32: 588-591
39. Nakai N, Takenaka H, Kishimoto S. Atypical fibroxanthoma on a bald scalp. J Dermatol 2005; 32 (10): 848-851
40. Lee D, Grossman ME, Schneiderman P, et al. Genetics of skin appendage neoplasms and related syndromes. J Med Genet 2005; 42: 811-819
41. Zhang X, Liang YH, He PP, et al. Identification of the cylindromatosis tumorsuppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol 2004; 122: 658-664
42. Rallan D, Harland CC. Brooke-Spiegler syndrome: treatment with laser ablation. Clin Exp Dermatol 2005 Jul; 30 (4): 355-357
43. Santibanez-Gallerani A,Marshall D, Duarte AM, et al. Should nevus sebaceus of Jadassohn in children be excised? A study of 757 cases, and literature review. J Craniofac Surg 2003 Sept; 14 (5): 658-660
44. Bichakjian C, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007 Jul; 110 (1): 1-12
45. Clark J, Veness MJ, Gilbert R, et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007; 29: 249-257 (Pubitemid 46339322)
46. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008 Feb 22; 319 (5866): 1096-1100
47. Sihto H, Kukko H, Koljonen V, et al. Clinical factors associated with Merkel cell polyomavirus infection inMerkel cell carcinoma. J Natl Cancer Inst 2009; 101: 938-945
48. Gandhi RK, Rosenberg AS, Somach SC.Merkel cell polyomavirus: an update. J Cutan Pathol 2009 Dec; 36 (12): 1327-1329
49. Stein R, Spencer JM. Painful cutaneous metastases from esophageal carcinoma. Cutis 2002 Oct; 70 (4): 230-232
50. Sabir S, James W, Schuchter L. Cutaneous manifestations of cancer. Curr Opin Oncol 1999 Mar; 11 (2): 139-144
51. Cohen P. Skin clues to primary and metastatic malignancy. Am Fam Physician 1995; 51 (5): 1199-1204
52. Llancapi P, Gutierrez R, Paiva O. Cutaneous metastases: clinical pathological review. Rev Med Chil 1996 Dec; 124 (12): 1519-1523
53. Mueller T, Wu H, Greenberg RE, et al. Cutaneous metastases from genitourinary malignancies. J Urol 2004; 63: 1021-1026
54. Dahl P, Brodland DG, Goellner JR, et al. Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy. J Am Acad Dermatol 1997; 36: 531-537
55. Roh E, NordR, JukicDM. Scalp metastasis from esophageal adenocarcinoma. Cutis 2006 Feb; 77 (2): 106-108
56. Yuen Y, Lewis EJ, Larson JT, et al. Scalp metastases mimicking alopecia areata: first case report of placental site trophoblastic tumor presenting as cutaneous metastasis. Dermatol Surg 1998 May; 24 (5): 587-591
57. Rendi M, Dhar AD. Cutaneous metastasis of rectal adenocarcinoma. Dermatol Nurs 2003 Apr; 15 (2): 131-132
58. Boswell J, Davis MDP. Violaceous plaque on the forehead clinically resembling angiosarcoma: cutaneous metastasis in a patient with prostatic adenocarcinoma. J Am Acad Dermatol 2005 Oct; 53 (4): 744-745
59. Kushner D, Lurain JR, Fu TS, et al. Endometrial adenocarcinoma metastatic to the scalp: case report and literature review. Gynecol Oncol 1997; 65: 530-533
60. Shimizu S, Nagata Y, Han-yaku H. Metastatic testicular choriocarcinoma of the skin: report and review of the literature. Am J Dermatopathol 1996 Dec; 18 (6): 633-636
61. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol 2006 May; 13 (3): 114-121
62. Willemze R, Jaffe ES, BurgG, et al.WHO-EORTCclassification for cutaneous lymphomas. Blood 2005; 105: 3768-3785
63. Bogle M, Riddle CC, Triana EM, et al. Primary cutaneous B-cell lymphoma. J Am Acad Dermatol 2005; 53: 479-484
64. Whittaker S. Molecular genetics of cutaneous lymphomas. Ann N Y Acad Sci 2001 Sep; 941: 39-45
65. Gilliam A, Lessin SR, Wilson DM, et al. Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp. J Cutan Pathol 1997 Mar; 24 (3): 169-175
66. Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Clin Pathol 2006; 33 Suppl. 1: 58-70
67. Weiss L, Wood GS, Trela M, et al. Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986 Aug; 315 (8): 475-479
68. Campo E, Chott A, Kinney MC, et al. Update on extranodal lymphomas: conclusions of the workshop held by the EHAP and the SH in Thessaloniki, Greece. Histopathology 2006; 48: 481-504